The long history of HER2 testing in breast cancer is an indication of the importance of continuing efforts to improve HER2 diagnostic assays and their interpretation, to ensure that patients who may benefit receive the appropriate targeted therapy. The gene discussed is ERBB2; the disease is breast cancer.